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Abstract objectives Further scale-up of antiretroviral therapy (ART) to those in need while supporting the
growing patient cohort on ART requires continuous adaptation of healthcare delivery models. We
describe several approaches to manage stable patients on ART developed by Medecins Sans
Frontieres together with Ministries of Health in four countries in sub-Saharan Africa.
methods Using routine programme data, four approaches to simplify ART delivery for stable
patients on ART were assessed from a patient and health system perspective: appointment spacing for
clinical and drug refill visits in Malawi, peer educator-led ART refill groups in South Africa,
community ART distribution points in DRC and patient-led community ART groups in
Mozambique.
results All four approaches lightened the burden for both patients (reduced travel and lost income)
and health system (reduced clinic attendance). Retention in care is high: 94% at 36 months in
Malawi, 89% at 12 months in DRC, 97% at 40 months in South Africa and 92% at 48 months in
Mozambique. Where evaluable, service provider costs are reported to be lower.
conclusion Separating ART delivery from clinical assessments was found to benefit patients and
programmes in a range of settings. The success of community ART models depends on sufficient and
reliable support and resources, including a flexible and reliable drug supply, access to quality clinical
management, a reliable monitoring system and a supported lay workers cadre. Such models require
ongoing evaluation and further adaptation to be able to reach out to more patients, including specific
groups who may be challenged to meet the demands of frequent clinic visits and the integrated
delivery of other essential chronic disease interventions.
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Introduction
At the end of 2012, 9.7 million people were receiving an-
tiretroviral therapy (ART) in low- and middle-income
countries, more than three quarters of whom live in sub-
Saharan Africa (UNAIDS 2013). Continuing to provide
ART to a large and growing cohort poses a significant
challenge to health systems in a region where there is a
shortage of clinical staff (WHO 2006); this challenge is
highlighted by substantial rates of attrition reported
across ART programmes (Fox & Rosen 2010; Kranzer
et al. 2012). The pace of ART enrolment will likely fur-
ther increase in the coming years with recommendations
issued by WHO in 2013 to expand the eligibility criteria
for ART initiation, meaning that around 28.6 million
people are now considered eligible for ART (UNAIDS
2013; WHO 2013).
The last decade has seen a progressive decentralization
of ART care from hospitals to health centres, and more
recently out into the community, as a way to improve
access to care for patients and spread the workload for
healthcare workers (Mills et al. 2006; Bedelu et al. 2007;
Bemelmans et al. 2010; Fatti et al. 2010; Kredo et al.
2013). The challenges of further scaling up ART to those
in need and improving retention in care for those on
ART require continued adaptations in the models of
968 © 2014 John Wiley & Sons Ltd
Tropical Medicine and International Health doi:10.1111/tmi.12332
volume 19 no 8 pp 968–977 august 2014
healthcare delivery to the reality of people’s lives. The
2013 WHO Consolidated guidelines recommend that
provision of ART can be maintained in the community,
but operational guidance is needed for this to happen in
practice (WHO 2013). As national, provincial and dis-
trict teams address the various challenges, lessons from
innovative models of ART delivery can help shape the
next stages of HIV care and treatment scale-up.
This article describes a number of community-sup-
ported models of ART delivery developed by Medecins
Sans Frontieres (MSF) together with Ministries of Health
(MoH) in public health facilities in sub-Saharan Africa to
support ongoing efforts to manage an ever growing
cohort of people on ART.
Benefits of community ART delivery
Several studies have assessed the feasibility of separating
ART delivery from clinical visits by establishing models
of ART delivery at the community level. In these models,
health centres and hospitals serve as referral sites in case
of clinical need. In Uganda, survival and virological sup-
pression in a home-based ART delivery model were simi-
lar to facility-based ART (Jaffar et al. 2009); these
outcomes lasted up to 5 years (Okoboi et al. 2014). In
western Kenya, community-based care provided by peo-
ple living with HIV/AIDS (PLHIV) resulted in similar
clinical outcomes as usual care, but with half the number
of clinic visits (Wools-Kaloustian et al. 2009; Selke et al.
2010). In Tanzania, a model of ART delivery by commu-
nity-based volunteers linked to trained medical workers
has led to fewer patients being lost to follow-up from
treatment (Roura et al. 2009).
From a patient perspective, the main benefit of a com-
munity approach to ART delivery is to reduce the finan-
cial and time costs associated with frequent clinic visits.
Another objective is to encourage community-based peer
support. The relationship between social support and
improved adherence to treatment is well established (Rue-
da et al. 2006; Ware et al. 2009), and the engagement of
people living with HIV in service delivery can provide an
additional accountability mechanism to ensure continuity
and quality of care (Monitoring Essential Medicines Con-
sortium 2013).
From a health system perspective, reducing clinic con-
tact required for clinically stable ART populations and
refocusing resources towards managing sick patients with
complex clinical problems is a key objective, with antici-
pated reduction of staff workload and improvements in
quality of care and programme outcomes (Decroo et al.
2013). There is no agreed definition of stable patient, but
broadly, this requires that the patient has been taking
ART successfully for a minimum period of time, has no
concurrent illness, has experienced a degree of immune
recovery and is demonstrated to be adherent to ART
(Meintjes et al. 2012).
Different strategies for different contexts
Models of ART delivery are context specific and depen-
dent on a range of factors, including patient barriers to
retention in care, the extent of service decentralization
and task shifting to lay health worker cadres, HIV preva-
lence, the availability of safe and simple ART regimens,
health service capacity, and regulatory or logistical con-
straints to ART delivery. In this article, four related
approaches to simplifying ART delivery are summarised
in Table 1. Key features of each model are provided in
Table 2, and outcomes are summarised in Table 3.
Reducing appointment frequency in Malawi
Medecins Sans Frontieres has been supporting HIV and
TB activities in Chiradzulu district in Malawi (population
320 000) since 1997. Since ART was first introduced in
2001, HIV care has been progressively decentralised from
the hospital to 10 health centres in order to support
scale-up and improve retention in care. By mid-2013, a
total of 27 607 active patients were on ART. In 2008, a
new protocol for appointments was established (McGuire
et al. 2011), allowing stable adult patients to attend the
clinic once every 6 months for clinical assessments
instead of every 1–2 months for patients in regular ART
care. Health surveillance assistants (HSAs), who are paid
community health workers and part of the MoH, provide
three-monthly ART refills at health centres. Eligibility
and adherence are monitored continuously according to a
standardised assessment tool. When problems arise, HSAs
refer patients back to the clinical staff for consultations.
Between January 2008 and mid-2013, 8528 patients
have been enrolled in the six-monthly appointment
(SMA) system (manuscript in preparation). Approxi-
mately one-third (2722) of enrollees have returned to reg-
ular care on at least one occasion, of whom 516 (19%)
have resumed participation to date. The main reasons for
returning back to regular care for extended periods are
pregnancy and breastfeeding.
Although interruptions are common, 8040 (94.3%) of
cumulative enrollees remain active in the ART cohort
after 36 months, with a median follow-up of 25 months
[IQR: 13–43] since their first enrolment. This compares
to 83% retention after 36 months for patients eligible
for, but not enrolled in the SMA system. Among SMA
participants, loss to follow-up and mortality rates at 1, 2
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and 5 years since enrolment were 1.3%, 2.98% and
7.8%, and 0.4%, 0.9% and 2.8%, respectively. The pro-
gramme is currently undertaking a comparative analysis
against patients who have qualified for the SMA pro-
gramme, but remained in usual care.
Other countries, including Uganda, South Africa and
Zimbabwe, have taken a similar approach, adapting
pharmacy regulation and practice to allow for longer
supplies of antiretroviral drugs in combination with
spaced appointments (Nakiwogga-Muwanga et al. 2014).
Adherence clubs in South Africa
In Khayelitsha, South Africa, ART provision started in
2001 and by mid-2013 more than 25 000 people
remained in care. As the number of patients on ART
increased rapidly in the country, the loss to follow-up
rate also began to rise (Boulle et al. 2010; Cornell et al.
2010). In response, several service adaptations were
implemented to relieve pressure on clinics by moving
towards a nurse-based, doctor-supported decentralised
model of care and by developing out-of-clinic approaches
to adherence support for stable patients.
Facility-based ART adherence clubs were piloted in
2007 as a way to decongest facilities by shifting consulta-
tions and ART collections for stable patients to clubs
organised by peer educators at the clinic. Groups of up
to 30 patients meet every 2 months for less than an hour.
Participation is offered to all adults who have been on
ART for at least 12 months and are considered clinically
stable with an undetectable viral load. In these groups,
essential tasks such as weighing patients and symptom-
based general health assessments are carried out and
recorded by a peer educator and/or lay counsellor who
acts as the club facilitator. As pharmaceutical regulation
requires a dispensing licence, antiretroviral (ARV) drugs
Table 1 Summary of strategies for alternative models for delivery of long-term ART
Health Service Driven Patient Driven
Key objective
Appointment
spacing and fast-
track drug refill
Adherence clubs
Community ART
distribution points
(PODI)
Community ART
groups (CAGs)Facility-based clubs
Community-based
clubs
Patient perspective
Reduce costs (time
and transport)
Reduction of
clinical visits
Reduction of
clinical visits
Reduction of
clinical visits
Reduction of
clinical visits
Reduction of
clinical visits
Less time spent at
clinic for drug
refill
Less time spent at
clinic for drug
refill
Reduction of
distance for drug
refill
Reduction of
distance for drug
refill
Reduction of
distance for drug
refill
Increase peer
support
No At club in health
facility
At club in
community
At distribution
point by expert
patient
At CAG meeting in
community
Enhance
community
participation
No Potentially Potentially Potentially Yes
Healthcare service perspective
Reduce workload
Nurse Yes Yes Yes Yes Yes
Pharmacist Yes Yes No Yes Yes
Counsellor/CHW/
expert patient
Not applicable No No No No
Maintain/improve health outcomes
Adherence Unknown Yes Unknown Unknown Unknown
Retention Yes Yes Unknown Yes Yes
Improve self-
management of
patients
Individual patient
empowerment
Adherence support Adherence support
and tracing
Organisation of
services for drug
refill, adherence
support, tracing
and testing
Drug refill,
adherence support,
tracing, testing
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are pre-packaged by pharmacy staff, labelled for each
participant and brought to the group by the club facilita-
tor. Any patient reporting weight loss or other symptoms
suggesting illness or drug side effects is referred back to
the main clinic for assessment by a nurse. All club partic-
ipants see a nurse twice a year for blood tests and clinical
check-up. The club facilitator is also responsible for com-
pletion of the club register as the patient files are only
drawn for the annual clinical check-up (Wilkinson 2013).
A cohort analysis comparing patient outcomes of those
joining adherence clubs (502) and those who were eligi-
ble but remained in standard care (2327) found that over
40 months, club participation reduced the number of
patients lost to care by 57% [adjusted hazard ratio (HR)
0.43, 95%CI 0.21–0.91] and virological rebound by
67% (HR 0.33, 95%CI 0.16–0.67) (Luque-Fernandez
et al. 2013). The improved outcomes in the adherence
clubs were determined to be the result of shorter waiting
times, higher acceptability of services and consequently
fewer missed clinic appointments. A cost-effectiveness
study showed the cost per patient year was US$58 in the
ART club model, vs. US$109 in the mainstream model of
care. (Bango et al. 2013).
This model was taken up by the City of Cape Town and
Western Cape health services in 2011, and by June 2013,
all 10 Khayelitsha clinics were running 221 facility-based
clubs accounting for almost a quarter (23%) of patients on
ART. In total, 776 adherence clubs had been implemented
across Cape Town supporting approximately 18 700
patients, which represents one in five (19%) of all ART
patients in care in the metropolitan area.
Since May 2012, MSF has piloted an extension of this
model into the community, with clubs meeting in
patients’ homes or at community venues, with pre-packed
drugs and blood specimen collection carried out at com-
munity heath points. As of July 2013, there were 10 com-
munity clubs in Khayelitsha.
Community ART distribution points in DRC
In DRC’s capital Kinshasa (population 10 million),
patients can pay high transport costs to reach the few
health facilities providing ART in the city. Patients also
need to pay for their consultations, which together with
transport can result in up to $40 monthly expenses,
almost half of a Congolese average monthly salary. As a
consequence, many patients only enter care with
advanced HIV illness.
In this low-ART coverage context, MSF together with
a local network of people living with HIV established
Table 2 Key features of models
Appointment
spacing and
fast-track drug
refill
Adherence clubs
Community ART
distribution points
(PODI)
Community ART
groups (CAGs)
Facility-based
clubs
Community-based
clubs
Country Malawi South Africa South Africa DRC Mozambique
Context Rural Urban Urban Urban Rural
Active ART cohort 27 607 (7/2013) 25 991 (6/2013) 5028 (7/2013) 16 362 (7/2013)
Programme initiation 1/2008 11/2007 5/2012 12/2010 2/2008
Eligibility Adult (≥15 years)
on 1st line ART
≥12 months w/
CD4 count ≥ 300,
without OI/side
effects, pregnancy
or breastfeeding*
Adult on 1st line ART ≥12 months
with two undetectable viral load
On 1st line ART
≥6 months w/CD4
count ≥ 350,
without OI/side
effects
On 1st line ART
≥6 months w/CD4
count ≥ 200,
without OI/side
effects
Frequency of ART
refill
Every 3 months Every 2 months Every 3 months Monthly
Mode of ART refill Individually at clinic Collectively at lay worker-led club Individually at
distribution point
Collectively at
patient-led CAG
Frequency of clinical
visit
Every 6 months for
clinical
consultation,
yearly viral load
Yearly for viral load and clinical
consultation
Yearly for CD4 and
clinical
consultation
Every 6 months for
combined drug
refill, clinical
consultation, CD4
ART, antiretroviral therapy; OI, opportunistic infection.
*Continuation reviewed every 6 months per eligibility guidelines.
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community ART distribution points in Kinshasa, free of
charge, bringing drug delivery closer to patients’ homes
from late 2010 onwards. These distribution points are
managed by PLHIV who are trained to provide ART
refills, adherence support and follow-up of basic health
indicators. Stable patients on ART attend the distribution
point every 3 months for drug refill and report to the
health service annually for clinical consultation and blood
drawing for CD4 count testing. Referral to clinic care is
done by the lay worker, and patients who do not show
up for their appointments are traced by the peer counsel-
lors by phone or through the network of local support
groups. The distribution points also offer free HIV testing
and counselling at community level.
As of July 2013, 2162 patients had been referred to
one of the three community ART distribution points –
representing 43% of patients on ART. A cohort survival
analysis between October 2010 to May 2013 shows that
89.3% of patients (n = 1935) were retained after
12 months and 82.4% at 24 months post-transfer to the
distribution points (Kalenga et al. 2013). Mortality was
<1%, although there may be some misclassification
among patients lost to follow-up (7.6% at 24 months).
While this study made no direct comparisons, these
results compare favourably with reported retention rates
of 75–85% at 12 months elsewhere in DRC (Loando
2009; Koole et al. 2012).
The average cost of human resources expenditure per
patient is lower at community distribution points than at
the clinic, while transport costs for patients are about
three times lower compared with hospital-based care.
There are also considerable time savings: patients at the
community ART distribution points spend an average of
14 min collecting ART refills compared with 85 min at
the hospital (Jouquet 2011).
The MoH has recognised the distribution points as one
of the good practices for community-based access to
ART in their recent national strategic plan as well as
their recent application to the Global Fund to Fight
AIDS, Tuberculosis and Malaria (CCM, DRC 2013;
PNMLS 2013).
Community ART Groups in Mozambique
By the end of 2012, close to 300 000 patients had been
initiated on ART in Mozambique. However, just 74%
were alive on ART after 12 months and 51.6% after
3 years of ART initiation (Ministry of Health Mozam-
bique 2009; Wandeler et al. 2012). In 2008, this high
attrition figure, combined with increasing numbers of
patients required to travel to a health facility every
month to collect drugs and the limited number of clinics
still providing ART, prompted the government with
support from MSF to launch a pilot programme of
community-based ART distribution and adherence moni-
toring in Tete Province (Decroo et al. 2011).
In this programme, stable patients organise themselves
into groups of six, taking turns to collect ARVs every
month for group members. Each member has contact
with the clinic every 6 months for a medical check and
CD4 count testing, and in case of problems, patients self-
refer to clinic or are referred by other community ART
group (CAG) members (Decroo et al. 2011). A retrospec-
tive cohort study between February 2008 and December
2012 found that of 5729 CAG members, mortality and
loss to follow-up rates were, respectively, 2.1 and 0.1 per
100 person-years. Retention was 91.8% at 48 months
(Decroo et al. 2014).
Results from a qualitative study found high levels of
acceptance among patients as CAGs reduced the cost and
time burden on patients and provided peer support as a
way to support adherence. CAGs strengthened commu-
nity participation through information sharing and link-
ing people to care. Challenges involve the limited access
to CAGs for patients at high risk of loss to follow-up due
to strict inclusion criteria, as well as the lack of sustained
support for lay workers that have been critical for CAGs
to function well (Rasschaert et al. 2014).
Medecins Sans Frontieres has further refined the model
for children and adolescents. Children are included as
‘dependent members’ in CAGs, meaning that they join
the CAG representative on the trips to the clinic to
receive their monthly clinical visit and drug refill. As of
March 2012, 312 children below the age of 15 were
members of 225 different CAGs, representing 6% of all
CAG members. Retention among children in CAGs was
94% (Decroo et al. 2012).
The CAG model has also been successful in linking
people who test HIV positive to ART care. In a pilot pro-
ject in Changara district, Mozambique, CAG members
were recruited as paid community counsellors to offer
HIV testing to family or community members of CAG
participants and refer them to CD4 testing at the nearby
clinic. By September 2013, 3168 were tested with 273
(8.6%) testing positive, 115 (42%) of whom were eligible
for ART and from these, 102 (89%) started ART.
After this early success, the MoH recommended in July
2011 that CAGs be incorporated into the national HIV
care strategy and launched a national CAG pilot pro-
gramme (Decroo et al. 2009; Rasschaert et al. 2014) and
over 17 000 people were receiving ART in CAGs by the
end of 2013. Challenges faced by MoH in the scale-up of
CAGs include a lack of lay cadre to ensure links between
the community groups and the health facilities.
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Several MoH of neighbouring countries – including
Malawi, Lesotho, South Africa and Zimbabwe – have
begun piloting CAGs. The model has been further
adapted to these contexts through adaptation and
simplification of procedures, tools and visit schedules to
national standards and intensive collaboration with
local networks of people living with HIV. Similar high
retention in CAGs is observed in these programmes,
while acceptance of CAGs is especially high in rural
settings (Baert et al. 2013). A study in Malawi shows
the decongestion of health facilities through CAGs, as
clinic visits reduced by 49.6% for CAG members
between the pre- and post-CAG enrolment period. This
was mainly related to a decreasing number of ART
refill visits, while health seeking behaviour for other
health problems did not seem to have substantially
changed (Billaud et al. 2013).
Discussion
These different community supported models have shown
good patient outcomes for patients stable on ART. Where
assessed, outcomes are similar to or better than compara-
ble cohorts of patients who remain in standard care, and
there is some evidence of cost saving.
As is commonly the case for the introduction of new
interventions, all the models described in this review
received initial support from an international NGO
(MSF). Nevertheless, subsequent expansion has been
achieved as part of MoH national plans with limited
international partner support (Decroo et al. 2013; Wil-
kinson 2013; WHO 2014), which is encouraging in terms
of scalability and sustainability. Important lessons con-
tinue to be learned from the ongoing roll-out of these
models at scale.
In a technical update released in 2014, WHO put for-
ward a number of critical enablers for the success of
community models of care, including the need for a reli-
able and flexible ARV drug supply system, appropriate
lay cadres to support these models and adapted
approaches for monitoring and evaluation (WHO 2014).
Firstly a reliable drug supply is needed for these models
to function. In Thyolo district, Malawi, supply chain
weaknesses leading to ART stock-outs led temporarily to
a decrease in incentive for patients to join CAGs. Reduc-
ing health service contact will likely require a change in
prescribing policies to permit ART dispensing of more
than a month’s supply. This is currently allowed in most
countries, but limited by insufficient volumes in drug sup-
ply or delays or shortage in funding. The recent switch in
most countries to a first-line ART regimen – tenofo-
vir + lamivudine/emtricitabine + efavirenz – provided as
a fixed-dose combination for all adults can be expected
to simplify drug supply and improve adherence, further
supporting community-based models of care (Ramjan
et al. 2014; WHO 2014).
In each of these models, community workers are
involved in new key tasks that support these community
models in establishing, training, monitoring and facilitat-
ing the groups, as well as performing some basic clinical
responsibilities such as symptom-based general health
assessments. The limited engagement of lay staff in many
countries has been identified as a threat to the national
roll-out of the CAGs in Mozambique (Rasschaert et al.
2014). Given the precedents for such lay dispensing in
other areas of health care, such as the model of commu-
nity case management of malaria (Chanda et al. 2011),
and WHO’s recent recommendation that trained and
supervised community health workers dispense ART
between regular clinic visits (WHO 2013), such restric-
tions should be lifted. A critical challenge in many coun-
tries is the lack of a framework to support lay or basic
trained workers as part of the overall health service, with
corresponding remuneration and retention packages and
adequate supervision often lacking (Ledikwe et al. 2013;
Mwai et al. 2013). A major stumbling block for MoH is
the unwillingness to include a new cadre in their wage
bill envelope with already existing cadres facing difficul-
ties with remuneration and retention.
Self-managed care is dependent on reliable referral to
health professionals if the patient’s health deteriorates as
well as maintaining a minimal contact with health ser-
vices (every 6–12 months) to ensure a minimum level of
clinical and biological monitoring. This is all the more
important in resource-limited settings where mortality
rates among people on ART continue to be higher than
in developed countries (UNAIDS 2013). Part of ensuring
this minimal level of clinical management was achieved
in these models by equipping patients to provide peer
adherence support and education on how to identify
potential signs and symptoms such as TB, other common
opportunistic infections, significant weight loss or ARV-
specific toxicity.
Community stakeholders have been consulted in the
planning and implementation of community-based mod-
els in DRC and the recent pilot of CAGs in Malawi,
Zimbabwe and Lesotho. Early experience shows that the
collaboration with local networks of PLHIV has the
potential to stimulate stronger demand of accountability
from the health system, through a ‘watchdog’ to monitor
drug stock-outs or other breakdowns in quality of patient
care. The current trend of reduced funding from interna-
tional partners for these networks is a concern (CIVICUS
2013).
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Finally, monitoring and evaluation is an are essential
part of any community model. Accountability for patient
clinical management, defaulter tracing and ARV manage-
ment will need to be preserved while maintaining a trou-
bleshooting capacity when confronted with inevitable
individual patient or patient groups’ problems.
Conclusions
Community-supported models of ART delivery aim to
respond to the need to provide care to an ever increasing
number of people on ART. Observed benefits for patients
include reduced transport costs, improved peer support
and increased community participation to support adher-
ence. More rigorous research on patient outcomes in
community-supported models of care in comparison with
standard models of care is needed to validate the effec-
tiveness of such strategies. From a health system perspec-
tive, advantages include a reduction of workload for
clinical staff whilst improving health outcomes, plugging
various leaks of the cascade and encouraging patients’
autonomy. Where it has been assessed, costs and health
provider workload for HIV care have been reduced.
Certain strategies such as appointment spacing and
extended drug supplies benefit all patients who are stable
and adherent and as such could be offered in most set-
tings. Additional strategies that involve participation in
groups such as adherence clubs or community ART
groups, implying disclosure of HIV status, can be offered,
but participation will always be voluntary and the choice
of model will be context dependent. Providing extended
drug supplies in combination with a group strategy will
make it possible for patients to choose the model that
best suits their needs.
Realistic planning and flexible adaptations are crucial;
otherwise, the shortcomings of the health system will be
carried over into community care. Key enabling factors
include flexibility of drug supply, a reliable monitoring
system, clear referral mechanisms between the commu-
nity and health facility, provision of free care to access
HIV-related services and supervision and remuneration
for lay workers involved in supporting these models.
Implementing science research on the roll-out of these
models by MoH will help to assess the feasibility of such
roll-outs as well as the conditions that need to be in place
for these models to succeed.
Community-based ART delivery models may come at
an initial cost, but are likely to be cost savings over tradi-
tional facility-based models of care, and there is already
some evidence that this is the case. Over time, there will
likely be a need for further simplification of ART delivery
within the community, including more flexible entry crite-
ria as well as strategies directed towards patients with
specific needs and at high risk of loss to follow-up, such
as children, pregnant women, commercial sex workers
and migrants, and the integrated delivery of other essen-
tial chronic disease interventions.
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